. Introduction
morbidity and mortality of HIV/AIDS patients [1, 2] . HIVrelated cardiovascular disease was first recognized in the Following the advent of highly active antiretroviral early 1980s, primarily via autopsy cases in which myocartherapy (HAART) regimens, AIDS-free living and overall ditis and cardiac inflammatory lesions were observed in survival have significantly improved for patients infected hearts from AIDS patients with no documented evidence with human immunodeficiency virus (HIV) [1] . However, of cardiovascular disease [3, 4] . Later studies demonstrated a variety of HIV-related complications have become that HIV/AIDS patients develop an array of cardiovascular increasingly evident in this population. For example, HIVpathologies, ranging from left ventricular deficits in prerelated pulmonary, neurological, and cardiovascular comsymptomatic seropositive individuals to pulmonary hyplications represent important contributors to the overall pertension, dilated cardiomyopathy and congestive heart failure [5, 6] . The prevalence of cardiac complications in HIV patients has been estimated to be as high as 80%, with [18] . Therefore, we tested the hypotheses that cardiac NOS an estimated 5-20% progressing to dilated car-II expression and / or cardiac protein nitration are associdiomyopathy and failure [1, 7] . As the worldwide incidence ated with time dependent cardiac dysfunction during of AIDS approaches an estimated 5,000,000 new cases murine AIDS progression. annually, HIV-related cardiovascular disease may become To corroborate our experimental findings in the murine a significant etiology of cardiac failure [8, 9] . The mecha-AIDS model, we explored the relevance of our experimennisms by which this unique form of cardiovascular disease tal results in a sample of cardiac autopsy tissues from develops and its relation to more traditional settings (non-HIV/AIDS patients with dilated cardiomyopathy and relretroviral) of cardiomyopathy remains incompletely deevant controls. fined. As a result, no specialized therapeutic approaches for this patient population currently exist.
Unfortunately, the study of relationships between human 2 . Methods HIV infection and cardiac alterations is often complicated by the use of various drug therapies, illicit drugs known to 2 .1. Murine AIDS model and study design be cardiotoxic, limited tissue availability and variable disease progression [10] . Demonstration of relevant animal
All aspects of our animal use were in accordance with models for the investigation of retrovirus-related cardiac the guidelines of the National Institutional of Health and dysfunction and pathologies could provide opportunities approved by the Institutional Animal Care and Use Comfor further mechanistic insight and therapeutic intervenmittee. Active LP-BM5 virus was prepared according to tion. In this study, we employed a well-established murine the methods of Watson et al. [19] . Retrovirus-containing model of retroviral infection (LPBM5 virus) and defined cell-free supernatant was collected from infected SCI / the time-dependencies of retroviral progression and cardiac MuLV cells (AIDS Research and Reference Reagent dysfunction, in an attempt to extend its relevance as a Program, Bethesda, MD, USA), and concentrated by disease model. The LPBM5 model of retroviral infection is centrifugation (Advanced Biotechnologies, Columbia, MA, commonly called the 'murine AIDS' model, due to its high USA). Titers of esotropic MuLV were determined by the similarity to many of the immune-related complications standard S'L plaque assay [20] and by units of reverse seen during human HIV infection, including aberrant transcriptase activity using a commercially available kit cytokine release, changes in T-cell populations, and in-(Boehringer Mannheim, Germany). creased susceptibility to opportunistic infections (for a Pathogen-free female C57BL / 6 mice (Harlan Laboratordetailed review see Watson 1989 [19] ).
ies, Indianapolis, IN, USA) were housed in a sterile cage An additional goal was to define the contributions of rack system with HEPA filtered air circulation (approxinitric oxide (NO)-related biochemistry during murine mately 50 air changes / h, Allentown Caging, Allentown, retrovirus related cardiac dysfunction. Under normal phys-PA, USA). Following 1-2 weeks of acclimatization LPiological conditions, NO is known to modulate cardiac BM5 retrovirus was dosed via a single intraperitoneal myocyte contractility and blood flow distribution [11] . In injection (100 ml dose containing 200 reverse transcriptase contrast, high levels of NO production (via inducible nitric units). Control animals received an identical injection of oxide synthase, NOSII) are associated with several forms vehicle. At the time of injection all mice were 6 weeks old of cardiac disease, and have recently been implicated in and weighed 16-18 g. human HIV-related cardiomyopathy [12] . Once formed, Cardiac performance was assessed by echocardiography, NO rapidly reacts with available superoxide anion to form as previously described [21] , at selected times throughout peroxynitrite, a reactive nitrogen species known to conduct 10 weeks of retroviral infection (8-12 per group). To several oxidative reactions in a cellular environment [13] .
account for time-variations, animal age and body weight, Of these, nitration of protein tyrosine residues, producing two groups of control animals were studied at 0 and 10 3-nitrotyrosine, is an unique feature of reactive nitrogen weeks post injection (n 5 6 in each group). Immediately species when compared to actions of reactive oxygen following echocardiography, animals were sacrificed by species (e.g., superoxide anion, hydroxyl radical, etc.) [14] . pentobarbital overdose. Spleen weight was measured as an We and others have demonstrated that reactive nitrogen index of retroviral progression, as documented by others species formation may be an important participant in the [19, 22] . initiation and / or progression of a wide array of cardiac pathologies and that nitration of protein tyrosine residues 2 .2. Reverse transcriptase-polymerase chain reaction can inhibit cardiac enzyme function, and promote cardiac (RT-PCR) for LPBM5 myocyte death via necrosis and / or apoptosis [15] [16] [17] . In addition, peroxynitrite mediated protein nitration has previTotal RNA was isolated from frozen cardiac and splenic ously been demonstrated in the setting of acute viral tissue (Trizol, Gibco BRL). RNA quantity was monitored myocarditis, but its contribution to cardiac dysfunction at 260 nm. RNA integrity was verified by fractionating on during retroviral pathogenesis has not been established agarose gels. Two mg of total RNA was reverse transcribed to cDNA (cDNA cycle kit, Invitrogen) in 20 ml reverse w / v) was used to provide visualization of immunoreactivitranscription reaction mix at 42 8C (60 min). The reaction ty, with methyl green counterstaining. was stopped by heat inactivation at 95 8C (2 min) and chilled on ice. Subsequently 5 ml of the resulting cDNA 2 .5. Digital image analysis was amplified using primers specific for the p12 region in the gag gene in the LP-BM5 genome [23] and b-actin Digital images were acquired using a Polaroid DMC [24] . The RTV primers: sense primer, 59-CCT camera and Olympus microscope (model BX40) and TTATCGACACTTCCCTT-39; antisense primer: 59-transferred to Image Pro Plus software (Media Cyber-CCGCCTCTTCTTAACTGGTC-39, similarly b-actin netics, Silver Spring, MD, USA) for both area and intensity primers: sense primer: 59-ATGGATGACGATATCGCTanalyses. Total cross-sectional images of spleen and heart 39; antisense primer: 59-ATGAGGTAGTCTGCTAGGT- 39 were captured at 43 magnification and circumferential were used in PCR reactions under the same conditions traces were used to calculate tissue areas. Images from which included an initial denaturation at 95 8C (5 min), cardiac samples assessed for specific immune infiltrates followed by a cycle of denaturation (95 8C / 1 min), anneal-(MPO1, CD681, mast cells, NOSII1) were captured at ing (55 8C / 1 min), and extension (72 8C / 1 min). Each 4003 magnification, positive cells were segmented and sample was subjected to 30 cycles followed by a final gated based on size, then counted and expressed per tissue extension (72 8C / 10 min). PCR products were separated area. In NOSII and 3NT studies, left ventricular images and visualized on a 2% agarose ethidium bromide stained were captured at 4003, and relative intensity was degel. Band intensity was assessed using imaging software termined using image threshold analysis, as we have (UVP-Labworks analysis), normalized to b-actin exprespreviously described [17] . sion in each tissue. Cardiac RTV expression was expressed as a percentage of splenic RTV expression.
.6. HIV/AIDS cardiac specimens

.3. Blood sampling and analysis
Left ventricular sections (LV anterior wall) were obtained as paraffin-embedded autopsy specimens from Whole blood was collected at sacrifice. Liver, pancreatic AIDS patients and non-HIV infected controls from the and muscle enzyme activity (AST, ALT, lipase and National Cancer Institute AIDS Cancer and Specimen amylase), as well as total cholesterol and triglyceride levels
Resource. All autopsy samples studied were collected were measured. Complete blood chemistries using whole within 4 h of death. Autopsy samples were collected blood smears were used to measure eosinophils, neutrobetween 1983 and 1998. Patient histories were reviewed to phils, monocytes and lymphocytes (Antech diagnostics).
subclassify samples into two groups: HIV infected patients with documented evidence of dilated cardiomyopathy 2 .4. Histology and immunohistochemistry (HIV-DCM, n 5 4) and non-HIV infected patients with no evidence of cardiac disease (CTRL, n 5 3). HIV/AIDS Following functional analyses, hearts were rapidly isopatients with confounding risk factors for cardiovascular lated, equatorially sectioned (mitral valve), and processed disease (smoking, diabetes, protease inhibitor therapy, etc.) for immunohistochemical studies using standard protocols were omitted from analysis. Age at autopsy was not [17] . Cardiac and splenic cross-sections were stained using different between patient groups (CTRL: 4062.3 yrs, HIVhematoxylin / eosin and Masson's trichrome for routine DCM: 36.563.2yrs, P 5 NS), and was not a significant morphologic and histologic assessments. Cardiac 3-nitrofactor for cardiovascular disease. Average ejection fraction tyrosine (anti-3NT antibody, Upstate Biotechnology, Lake in HIV1 patients with dilated cardiomyopathy was Placid, NY, USA, 1:400 dilution) and nitric oxide synthase 27.567.5%, mean CD41 counts were 123.5646.5 cells / 3 2 (anti-NOS2, Transduction Labs, Lexington, KY, USA, mm . These cardiac specimens were then assessed for 1:400 dilution) were assessed in cardiac cross-sections evidence of NOS II and protein-3NT, using immuno- [17] . Staining controls included antibodies preadsorbed histochemical methods identical to those described above. with purified 3NT or murine NOS II; addition of antigen eliminated positive staining in each case, demonstrating 2 . Splenomegaly is consistently observed in murine AIDS 2 are average total circulating blood monocytes, neutroand used as a marker of retroviral progression and immune phils, lymphocytes and eosinophil counts from control and dysfunction [19] . Representative mid-line splenic cross retrovirus infected animals. Total levels of monocytes in sections from control and LPBM5-treated mice at 10 whole blood were reduced at 5 and 10 weeks post infection weeks post-injection are shown in treated mice at 10 weeks. Hearts from RTV-treated mice LPBM5 infectivity is facilitated by the gag, pol, and env developed a hypertrophic response by 5 weeks, which genes [25] . The p12 region in the gag gene is unique to the persisted throughout the study (Fig. 3, middle panel) . LPBM5 virus and important to infectivity [26] . Shown in LPBM5-treated animals did not develop significant cach- significant increase in LV cross-sectional area (at the level of the mitral valve) was observed at 51 weeks post infection. This measure of LV mass (roughly a 25% increase from control) paralleled changes in total heart weight observed at 5 and 10 weeks.
.5. Time-dependent reduction in cardiac performance during murine AIDS
Cardiac performance was assessed at 5 and 10 weeks using echocardiography (Fig. 4) . No difference in heart respectively, relative to control (Fig. 4, Lower panel) . Reductions in fractional shortening were predominantly related to increases in LV end systolic dimension mast cells were not significantly elevated with retrovirus (1.7260.04 vs. 1.6060.02 mm at 10 weeks, RTV vs.
infection (P 5 NS). The levels of CD681 and neutrophils control).
(MPO1 cells) were not measured at 5 weeks post-infection, due to technical problems. Although changes in 3 .6. Cardiac immune cell prevalence during retroviral immune cell prevalence were detected by our imaging pathogenesis approach, we observed limited evidence of classical focal lesion sites in any region of the cross-sectional areas Leukocyte infiltration into cardiac tissue plays an imstudied. portant role in promoting and sustaining infectious cardiac diseases [27] . Shown in Fig. 5 are averaged data of cardiac infiltrating immune cells as measured by histochemical 3 .7. NOSII immunohistochemistry and cardiac protein techniques. Nominal presence of neutrophils and eosinonitration phils were detected at 10 weeks post-infection, whereas cardiac infiltration of CD681 cells (monocytes / macroRepresentative photomicrographs of cardiac NOS II and phages) was significantly increased at 10 weeks postprotein-3NT immunoprevalence during murine AIDS are infection, compared to controls (Fig. 5, Upper middle shown in Fig. 6 , where darker staining indicates positive panel). Cardiac presence of neutrophils, eosinophils, and immunoprevalence. NOSII content was not significantly altered in cardiac myocytes at 5 and 10 weeks postinfection, whereas sustained and extensive cardiac myocyte protein nitration was observed at 5 and 10 weeks relationships were observed between NOSII immunoprevalence and any cardiac functional parameter. non-ischemic dilated cardiomyopathy (HIV-DCM) and was confirmed by RT-PCR. Interestingly, LPBM5 was seronegative controls with no documented evidence of found to be present in cardiac tissue as well. The retroviral cardiac disease. Identical to our mouse studies, we obload in cardiac tissue was substantial (approximately 50% served striking evidence of cardiac myocyte protein-3NT of the splenic retroviral load), suggesting that retrovirus is formation, with no corresponding increases in NOSII likely infecting cardiac myocytes. The presence of HIV in presence. Similar to the murine studies described above, cardiac myocytes themselves has been highly controver-NOS II positive mononuclear cells were detected among sial; a few recent studies have documented its presence in the cardiac tissue cross-sections in this small population of human myocytes in vivo [31] and its potential to weakly HIV/AIDS patients and these were spatially dissociated infect rat cardiomyocytes, but not replicate, in vitro [32] . from cardiac myocyte protein nitration.
However, studies in simian models of retroviral infection have shown that SIV does not infect myocytes [33] . Our studies in cardiac homogenates did not establish the cell types infected, and cardiac load did not increase from 5 to 4 . Discussion 10 weeks, despite significantly worsening cardiac performance in RTV-treated mice. Further studies defining the Cardiovascular disease is a significant complication of direct role of cardiac myocyte infection in RTV-related HIV/AIDS. However, the mechanistic study of this phedysfunction are ongoing in our laboratory. nomenon in humans has proven difficult. Here, we pursued LV systolic performance was significantly impaired the development of a relevant and convenient animal within 5 weeks of infection, seen measured by LV fractionmodel for the mechanistic study of retrovirus-related al shortening and stroke volume. These early performance cardiovascular dysfunction. Several recent reports have deficits occurred at a time known to precede overt immune described transgenic mouse models that express some deficiency in this model, a phenomenon similar to observacomponents of the HIV genome in mice; these animals tions in asymptomatic HIV patients [5] . Further declines in develop a variety of cardiac abnormalities, especially focal stroke volume and cardiac output were observed at 10 lesions and production of cardiac autoimmune antibodies weeks-a 35-45% reduction in cardiac output is consistent [28, 29] . While these studies have demonstrated that HIV with moderate to severe heart failure in mice. This biphasic related proteins may be cardiotoxic, a causal role for HIV decay of cardiac performance is similar to the presentation or associated proteins in cardiac muscle per se in humans of cardiac dysfunction in HIV/AIDS patients and suggests remains controversial [30] . An additional consideration of that more than one mechanism may be involved [34] [35] [36] . the existing transgenic mouse reports is the presence of
The relationships between initial cardiac contractility viral components and / or foreign proteins during developdeficits and later, more severe cardiac impairments are not ment, as opposed to an infectious exposure following well understood in this model or in humans. The identificadevelopment. Since a physiological response to retroviral tion of early markers of dysfunction, and a more complete pathogen (rather than direct pathogen actions) may play an understanding of their relevance to the development of important role in the cardiac complications of HIV/AIDS, progressive cardiac failure, may have predictive and / or we chose to employ a mouse model of retroviral infection.
preventative value in this patient population. Recent Although the retroviral pathogen is distinct from HIV, this studies have also shown that the effects of relevant model recapitulates several features observed in humans, cardiotoxins (alcohol, cocaine, coxsackievirus B3) are including aberrant cytokine release, changes in T-cell aggravated by concurrent retroviral infection [37, 38] . populations, and increased susceptibility to opportunistic Thus, important interactions may exist in the development infections. Here we tested the hypothesis that cardiovascuof RTV-induced cardiac injury in both mice and humans. lar dysfunction occurs during retroviral progression and A pathogenic role for the immune system in acute murine AIDS development.
cardiac injury as well as progressive cardiac and vascular The time course of murine AIDS development during disease is becoming increasingly apparent [27, 39] . The retroviral progression has been well characterized by interactions between immune cells and cardiac myocytes others (for a thorough review see Morse et al. [22] ). While may have particular relevance in the setting of RTV-and viral replication and increased cytokine profiles are detect-AIDS-related cardiac disease. While LPBM5 infection was able in the first few weeks post infection, overt immune associated with a striking reduction in circulating monodeficiency occurs at approximately 10 weeks [22] . Hallcytes, we observed selective infiltration of CD681 cells mark features of retroviral activity include B-cell proliferinto cardiac tissue, with no corresponding increases in the ation and splenomegaly [19] . Therefore, we used total cardiac residence of any other leukocyte studied (neutrospleen weight and viral load (by RT-PCR) as measurephils, mast cells, eosinophils). Monocytes / macrophages ments of retroviral replication and disease progression.
are carriers for both HIV and LPBM5, and recent studies in Progressive increases in spleen weight were observed humans have demonstrated that trafficking of HIV-infected throughout the study. LPBM5 presence in splenic tissue CD681 cells to the heart occurs in patients with AIDS-related cardiomyopathy [40, 41] . Macrophages are high the contributions of these infiltrates to the protein oxidative capacity production sites for reactive oxygen and reactive events and functional impairments in this setting are nitrogen species, and may contribute to cardiac oxidative warranted, and are ongoing in our laboratory. damage in this setting [42] . The factors involved in the To validate our murine findings, we conducted further recruitment and / or activation of these immune cells to the histopathological studies in human cardiac autopsy tissues heart remain unknown; further studies defining the molecufrom HIV seropositive patients with documented evidence lar interactions and consequences involved are ongoing in of AIDS-related cardiomyopathy, that were in decompenour laboratory.
sated heart failure (average ejection fraction 27%). We We observed a progressive increase in the cardiac observed striking increases in protein-3NT presence in presence of protein-3NT during the development of RTVcardiac tissue from patients with AIDS-related carrelated cardiac dysfunction. In contrast, NOSII levels were diomyopathy compared to HIV seronegative controls, not increased at any time point studied. In addition, while cardiac NOSII protein levels remained unchanged. significant associations between several measures of carThese results are in opposition to recent results published diac dysfunction and extent of cardiac 3NT immunoby Barbaro et al., which showed that increased cardiac prevalence were detected, whereas no such relationships NOSII staining may be a consistent phenomenon in AIDS were observed for NOS II. These findings suggest that patients with cardiac disease [12, 30] . As has been shown cardiac RNS formation and attendant protein nitration may in experimental studies, important context-and time-departicipate in RTV-related cardiac pathology, rather than pendencies may exist between the induction of NOSII (and NOS II induction. This is consistent with the bimolecular other extramitochondrial oxidases) and the formation of reaction kinetics of RNS formation, and supports the protein-3NT in cardiac tissue. Consistent with our exunder-appreciated concept that NOS II induction is not perimental studies, staining for protein-3NT predominated obligatory for promotion of RNS formation and the in cardiac myocytes themselves; immune cell infiltration sustained presence of protein-3NT in vivo [15, 17] . Stainmay incompletely explain the oxidative events (and pering patterns indicate that cardiac myocytes themselves haps the cardiac myocyte dysfunction) that were observed carried a majority of the heart's protein nitration burdenin this setting. staining was widespread throughout the myocardium and In summary, LPBM5 infection, a well-established exwas not confined to focal immune infiltrates. Further perimental model for the immunologic complications of studies defining the putative sources for RNS and intracel-HIV-infection, caused early cardiac contractility deficits lular targets for protein nitration in this setting are ongoing and later, more severe cardiovascular impairment in mice, in our laboratory.
with a time course that preceded the development of overt An important consideration in these studies was our immunodeficiency; the 'murine AIDS' model appears capacity to detect NOSII in situ-demonstrating that the appropriate for the mechanistic study of RTV-induced lack of NOSII positive staining was not a 'false negative' cardiac complications. Although the infectious agent was result. While we observed only nominal evidence of NOSII not HIV itself, the murine AIDS model recapitulates many prevalence in cardiac myocytes from murine RTV hearts, of the important features of AIDS-related cardiac disease we did observe intense positive staining for NOSII in in humans, suggesting that the systemic and / or carinfiltrative cells. We therefore quantified these cell bodies diovascular response to RTV infection may mediate many in controls and at 10 weeks of RTV infection, using of these changes, rather than direct effects of the virus methods identical to our cardiac infiltrate counts. We found itself. Although we observed dramatic changes in immune that the residence of NOSII positive infiltrates was incell levels and trafficking patterns, a number of structural creased at 10 weeks relative to controls, and that the and biochemical alterations occurred in the cardiac relative prevalence in these cells paralleled that of CD681 myocytes themselves in RTV-treated animals. itself may represent an important site of RTV-related capacity for the in situ detection of NOSII in cardiac pathogenesis. Here, we describe first-time evidence that tissue, and further validate the unexpected spatial dissociacardiac RNS formation and oxidative injury may play a tion between cardiac myocyte protein nitration and NOSII significant role in the development of cardiac complicaprevalence. In contrast to our finding of statistical associations in both the murine AIDS model and in a relevant tion between cardiac protein nitration and LV function, we population of AIDS-related cardiomyopathy patients. Furdetected no such relationship between NOS II intensities or ther studies defining the sources and putative intracellular positive cell prevalence and any of the functional parametargets of these oxidants will provide important mechanisters measured, thus suggesting that reactive nitrogen tic insights, and may reveal new therapeutic opportunities species may be more directly related to dysfunction than for this unique and important cardiovascular disease NO production capacity per se). Further studies defining setting.
